Obesity Featured Articles
-
Will Today’s Clinical Trial Trends Become Tomorrow’s Routine?
4/23/2024
Clinical trial trends can be divided into two groups — those related to changes in the conduct of clinical trials and those related to the changes in therapeutic areas. Will these trends hold steady as 2024 unfolds?
-
4 Ways Concomitant Medications Can Complicate Your Trial
4/22/2024
Concomitant medications (con-meds) significantly influence clinical trials, affecting duration, costs, and participant safety. However, they are often inadequately tracked and analyzed in studies.
-
10 Reasons To Avoid Using Excel For Clinical Trials
4/22/2024
As clinical trials become increasingly complex and global, learn why abandoning Excel for specialized applications becomes imperative for efficiency, accuracy, and cost-effectiveness.
-
10 Tips For Enabling Better Sponsor-CRO Collaborations
4/22/2024
By following these tips and investing in software tools, sponsors and CROs can optimize their partnerships and achieve greater success, leading to increased resource productivity and cost savings.
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
4/22/2024
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
Backup Sites: The Closers Of Clinical Trials
4/22/2024
With the rising complexity of trials and dwindling site availability, the adoption of backup sites has become increasingly commonplace, reflecting the industry's commitment to maximizing recruitment potential.
-
Diversity In Clinical Trials: Walking The Walk
4/22/2024
Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.
-
Why Can’t We Compare Site Performance Measures?
4/22/2024
Cerdi Beltré believes it’s possible to develop a global and objective way to measure investigator site performance for metrics such as startup duration, screen-pass rates, or rate of enrollment. It just won’t be easy … or make some sites happy.
-
Yes, Women’s Exclusion In Clinical Trials Is Still A Problem
4/22/2024
Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
4/19/2024
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.